TXG
10x Genomics Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
advancing human health requires a greater understanding of biology, and that understanding starts with the cell. we enable researchers to drive exponential progress in oncology, immunology, neuroscience, and more with novel single cell, spatial, and in situ tools that have been cited in over 3,000 publications and continually improved by our dedicated scientific team. our aim: to develop innovative instruments, reagents, and software that allow you to see your biological system at a resolution that matches its complexity.
Market Cap: 4.34 Billion
Primary Exchange: NASDAQ
Website: https://www.10xgenomics.com/
Shares Outstanding: 105 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 2.092553901811183
Sector: Professional, Scientific, and Technical Services
Industry: Testing Laboratories
Ethical Flags
Longest drawdown: 299 trading days
From: 2020-10-16 To: 2024-03-07
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|